A significant inverse association between the suppressor of cytokine signaling 1 (SOCS1) mRNA expression levels in the PBMCs of RA patients and disease activity was seen in four independent patient cohort studies comprising 281 RA patients, a finding that can guide prognostic stratification and treatment decisions (66). The gene discussed is SOCS1; the disease is rheumatoid arthritis.